Cargando…

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD

BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Kate M, Safari, Abdollah, Tan, Wan C, Bourbeau, Jean, FitzGerald, J Mark, Sadatsafavi, Mohsen, study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD)
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296193/
https://www.ncbi.nlm.nih.gov/pubmed/30587954
http://dx.doi.org/10.2147/COPD.S184424
_version_ 1783381001946267648
author Johnson, Kate M
Safari, Abdollah
Tan, Wan C
Bourbeau, Jean
FitzGerald, J Mark
Sadatsafavi, Mohsen
study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD)
author_facet Johnson, Kate M
Safari, Abdollah
Tan, Wan C
Bourbeau, Jean
FitzGerald, J Mark
Sadatsafavi, Mohsen
study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD)
author_sort Johnson, Kate M
collection PubMed
description BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated with this heterogeneity are not well understood. METHODS: A sample of the general Canadian population ≥40 years with persistent airflow limitation was followed for up to 3 years. Participants reported whether they experienced chronic coughing, phlegm, wheezing, or dyspnea during visits at 18-month intervals. We used mixed-effect logistic regression models (separately for each symptom) to assess overall heterogeneity in the occurrence of symptoms between individuals, and the proportion of variation in symptom burden explained by lung function vs all other clinical characteristics of participants. RESULTS: Four hundred forty-nine participants (53% male, mean age 67 years) contributed 968 visits in total, and 89% of patients reported at least one symptom during follow-up. There was substantial heterogeneity in the individual-specific probabilities for the occurrence of symptoms. This heterogeneity was highest for wheeze and dyspnea (IQR of probabilities: 0.13–0.78 and 0.19–0.81, respectively). FEV(1) explained 28% of the variation between individuals in the occurrence of dyspnea, 8% for phlegm, 3% for cough, and 2% for wheeze. All clinical characteristics of participants (including FEV(1)) explained between 26% of heterogeneity in the occurrence of cough to 49% for dyspnea. CONCLUSION: There is marked heterogeneity in the burden of respiratory symptoms between COPD patients. The ability of lung function and other commonly measured clinical characteristics to explain this heterogeneity differs between symptoms.
format Online
Article
Text
id pubmed-6296193
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62961932018-12-26 Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD Johnson, Kate M Safari, Abdollah Tan, Wan C Bourbeau, Jean FitzGerald, J Mark Sadatsafavi, Mohsen study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD) Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: The burden of symptoms varies markedly between patients with COPD and is only weakly correlated with lung function impairment. While heterogeneity in lung function decline and exacerbations have been previously studied, the extent of heterogeneity in symptoms and the factors associated with this heterogeneity are not well understood. METHODS: A sample of the general Canadian population ≥40 years with persistent airflow limitation was followed for up to 3 years. Participants reported whether they experienced chronic coughing, phlegm, wheezing, or dyspnea during visits at 18-month intervals. We used mixed-effect logistic regression models (separately for each symptom) to assess overall heterogeneity in the occurrence of symptoms between individuals, and the proportion of variation in symptom burden explained by lung function vs all other clinical characteristics of participants. RESULTS: Four hundred forty-nine participants (53% male, mean age 67 years) contributed 968 visits in total, and 89% of patients reported at least one symptom during follow-up. There was substantial heterogeneity in the individual-specific probabilities for the occurrence of symptoms. This heterogeneity was highest for wheeze and dyspnea (IQR of probabilities: 0.13–0.78 and 0.19–0.81, respectively). FEV(1) explained 28% of the variation between individuals in the occurrence of dyspnea, 8% for phlegm, 3% for cough, and 2% for wheeze. All clinical characteristics of participants (including FEV(1)) explained between 26% of heterogeneity in the occurrence of cough to 49% for dyspnea. CONCLUSION: There is marked heterogeneity in the burden of respiratory symptoms between COPD patients. The ability of lung function and other commonly measured clinical characteristics to explain this heterogeneity differs between symptoms. Dove Medical Press 2018-12-13 /pmc/articles/PMC6296193/ /pubmed/30587954 http://dx.doi.org/10.2147/COPD.S184424 Text en © 2018 Johnson et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Johnson, Kate M
Safari, Abdollah
Tan, Wan C
Bourbeau, Jean
FitzGerald, J Mark
Sadatsafavi, Mohsen
study, On behalf of the Canadian Cohort of Obstructive Lung Disease (CanCOLD)
Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
title Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
title_full Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
title_fullStr Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
title_full_unstemmed Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
title_short Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
title_sort heterogeneity in the respiratory symptoms of patients with mild-to-moderate copd
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296193/
https://www.ncbi.nlm.nih.gov/pubmed/30587954
http://dx.doi.org/10.2147/COPD.S184424
work_keys_str_mv AT johnsonkatem heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT safariabdollah heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT tanwanc heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT bourbeaujean heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT fitzgeraldjmark heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT sadatsafavimohsen heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT studyonbehalfofthecanadiancohortofobstructivelungdiseasecancold heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd
AT heterogeneityintherespiratorysymptomsofpatientswithmildtomoderatecopd